Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Exoc5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Exoc5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of EXOC5 mRNA | CTD | PMID:22206623 | Exoc5 | Rat | 1-nitropyrene | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of EXOC5 mRNA | CTD | PMID:19041380 | Exoc5 | Rat | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of EXOC5 protein | CTD | PMID:31675489 | Exoc5 | Rat | aflatoxin M1 | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Aflatoxin M1 results in decreased expression of EXOC5 mRNA | CTD | PMID:30928695 | Exoc5 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of EXOC5 mRNA | CTD | PMID:16483693 | Exoc5 | Rat | antirheumatic drug | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of EXOC5 mRNA | CTD | PMID:24449571 | Exoc5 | Rat | aristolochic acid A | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of EXOC5 mRNA | CTD | PMID:33212167 | Exoc5 | Rat | arsenous acid | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EXOC5 protein] | CTD | PMID:26598702 | Exoc5 | Rat | atrazine | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of EXOC5 mRNA | CTD | PMID:22378314 | Exoc5 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | Exoc5 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EXOC5 mRNA | CTD | PMID:25181051 | Exoc5 | Rat | bisphenol A | decreases methylation | ISO | EXOC5 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of EXOC5 gene | CTD | PMID:31601247 | Exoc5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of EXOC5 mRNA | CTD | PMID:30816183 and PMID:32145629 | Exoc5 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of EXOC5 gene | CTD | PMID:28505145 | Exoc5 | Rat | Bisphenol B | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of EXOC5 protein | CTD | PMID:34186270 | Exoc5 | Rat | bisphenol F | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of EXOC5 protein | CTD | PMID:34186270 | Exoc5 | Rat | cadmium atom | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EXOC5 mRNA | CTD | PMID:35301059 | Exoc5 | Rat | cadmium atom | multiple interactions | ISO | Exoc5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EXOC5 mRNA | CTD | PMID:37325564 | Exoc5 | Rat | cadmium dichloride | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EXOC5 mRNA | CTD | PMID:35301059 | Exoc5 | Rat | cadmium dichloride | multiple interactions | ISO | Exoc5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EXOC5 mRNA | CTD | PMID:37325564 | Exoc5 | Rat | cadmium sulfate | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of EXOC5 mRNA | CTD | PMID:18654764 | Exoc5 | Rat | CGP 52608 | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to EXOC5 gene] | CTD | PMID:28238834 | Exoc5 | Rat | cisplatin | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of EXOC5 mRNA | CTD | PMID:27392435 | Exoc5 | Rat | cobalt dichloride | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of EXOC5 mRNA | CTD | PMID:18654764 | Exoc5 | Rat | diarsenic trioxide | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EXOC5 protein] | CTD | PMID:26598702 | Exoc5 | Rat | dibutyl phthalate | increases expression | ISO | Exoc5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of EXOC5 mRNA | CTD | PMID:17361019 and PMID:21266533 | Exoc5 | Rat | dicrotophos | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of EXOC5 mRNA | CTD | PMID:28302478 | Exoc5 | Rat | dorsomorphin | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Exoc5 | Rat | doxorubicin | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of EXOC5 mRNA | CTD | PMID:29803840 | Exoc5 | Rat | endosulfan | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Endosulfan results in increased expression of EXOC5 mRNA | CTD | PMID:26615145 | Exoc5 | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of EXOC5 mRNA | CTD | PMID:18035473 | Exoc5 | Rat | FR900359 | increases phosphorylation | ISO | EXOC5 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of EXOC5 protein | CTD | PMID:37730182 | Exoc5 | Rat | heptachlor | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [Insecticides results in increased abundance of Heptachlor] which affects the methylation of EXOC5 gene | CTD | PMID:34516295 | Exoc5 | Rat | ivermectin | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of EXOC5 protein | CTD | PMID:32959892 | Exoc5 | Rat | lead(II) chloride | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of EXOC5 mRNA | CTD | PMID:18654764 | Exoc5 | Rat | methidathion | decreases expression | ISO | Exoc5 (Mus musculus) | 6480464 | methidathion results in decreased expression of EXOC5 mRNA | CTD | PMID:34813904 | Exoc5 | Rat | methyl methanesulfonate | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of EXOC5 mRNA | CTD | PMID:23649840 | Exoc5 | Rat | methylmercury chloride | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of EXOC5 mRNA | CTD | PMID:28001369 | Exoc5 | Rat | miconazole | decreases expression | ISO | Exoc5 (Mus musculus) | 6480464 | Miconazole results in decreased expression of EXOC5 mRNA | CTD | PMID:27462272 | Exoc5 | Rat | ozone | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Ozone results in increased expression of EXOC5 mRNA | CTD | PMID:28652203 | Exoc5 | Rat | paracetamol | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of EXOC5 mRNA | CTD | PMID:21420995 | Exoc5 | Rat | quercetin | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of EXOC5 mRNA | CTD | PMID:21632981 | Exoc5 | Rat | resveratrol | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of EXOC5 mRNA | CTD | PMID:23557933 | Exoc5 | Rat | SB 431542 | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Exoc5 | Rat | sodium arsenate | decreases expression | ISO | Exoc5 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of EXOC5 mRNA | CTD | PMID:21795629 | Exoc5 | Rat | sodium arsenate | increases expression | ISO | Exoc5 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of EXOC5 mRNA | CTD | PMID:21795629 | Exoc5 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of EXOC5 mRNA | CTD | PMID:23411599 and PMID:34492290 | Exoc5 | Rat | titanium dioxide | decreases expression | ISO | Exoc5 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of EXOC5 mRNA | CTD | PMID:29264374 | Exoc5 | Rat | trichostatin A | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of EXOC5 mRNA | CTD | PMID:24935251 and PMID:26272509 | Exoc5 | Rat | trichostatin A | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA | CTD | PMID:27188386 | Exoc5 | Rat | triphenyl phosphate | affects expression | ISO | EXOC5 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of EXOC5 mRNA | CTD | PMID:37042841 | Exoc5 | Rat | triptonide | increases expression | ISO | Exoc5 (Mus musculus) | 6480464 | triptonide results in increased expression of EXOC5 mRNA | CTD | PMID:33045310 | Exoc5 | Rat | valproic acid | decreases methylation | ISO | EXOC5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of EXOC5 gene | CTD | PMID:29154799 | Exoc5 | Rat | valproic acid | decreases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of EXOC5 mRNA | CTD | PMID:23179753 and PMID:26272509 | Exoc5 | Rat | valproic acid | multiple interactions | ISO | EXOC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXOC5 mRNA | CTD | PMID:27188386 | Exoc5 | Rat | zoledronic acid | increases expression | ISO | EXOC5 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of EXOC5 mRNA | CTD | PMID:20977926 | |